STARTUP PROFILE

Somareality

COUNTRY
Austria
FOUNDED
2020
CATEGORY
Diagnostics and Assessment
Developing eye-tracking–based algorithms to extract neural signals and monitor cognitive processes in real time.
Visit website →
Neurofounders Insights
$   Funding   -
Seed
MODALITY
Biomarkers
FORM FACTOR
Software/app
INTERFACE DEPTH
Software
INDICATION
Research
TARGET USER
Mixed
REGULATORY STAGE
Research only
SOMAREALITY uses eye-tracking algorithms to infer cognitive processes in real time, placing it in the machine-learning-based digital biomarker category. It appears closer to research and experimental analytics than a defined clinical product company.
Mentioned in Market Notes
MOST RECENT COVERAGE
#
3
The Big June Data Dump
9 June – 23 June 2026

Somareality closed an oversubscribed Series A of more than €3M led by Catalyst Romania, with existing investors MT-Lab, RDY Ventures, Moondust Ventures, and Gateway Ventures participating. The Vienna-based startup builds hardware-agnostic algorithms that infer cognitive states such as load, attention, and fatigue from eye-tracking data, generating digital biomarkers as an alternative to EEG and fNIRS. The capital is directed at expanding its B2B segments, funding longitudinal cognitive-health studies, and a planned move into the consumer space.

Articles featuring
Somareality